FDA Inspection
Octapharma Plasma, Inc.Octapharma Plasma, Inc. – FDA Inspection, Jan 23, 2012
Record Details
This FDA Inspection record concerns Octapharma Plasma, Inc., with an inspection on January 23, 2012, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Octapharma Plasma, Inc.
- Inspection Date
- January 23, 2012
- Product Type
- Biologics
View Company Profile
ID · 51306422-e752-4a64-a67d-040090123afd
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 766276
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
2- 21 CFR 606.60(b)Equipment calibration frequency
- 21 CFR 600.10(b)Personnel capabilities
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Octapharma Plasma, Inc.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| May 11, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 30, 2014 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 11, 2012 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Octapharma Plasma, Inc.
- FDA Inspection 1059959 - 2018-05-11
- FDA Inspection 887635 - 2014-06-30
- FDA Inspection 796542 - 2012-07-11
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.